General Information
Revision date
2019-06-20
Product name
OSELTAMIVIR PHOSPHATE CAPSULES 30, 45 & 75 mg
CAS No.
204255-11-8
1.2.1 Relevant identified uses
Oseltamivir phosphate capsule is an influenza neuraminidase inhibitor (NAI) indicated for ·Treatment of acute, uncomplicated influenza A and B in patients 2 weeks of age and older Who have been symptomatic for no more than 48 hours ·Prophylaxis of influ...
Emergency telephone
+91 - 265 - 228 0550, +91 - 265 - 228 1508
Icons in SDS
Company Information
company name
Alembic Pharmaceuticals Limited
GHS Information
Signal word
Danger
Section 2
SECTION 2: Hazards identification
Fire and Explosion Combustible solid which burns but propagates flame with difficulty. Health: If swallowed immediately call a poison centre or doctor/ physician.
Signal word
Danger Warning: ·Serious skin/hypersensitivity reactions such as Stevens-Johnson Syndrome, toxic epidermal necrolysis and erythema multiform: Discontinue oseltamivir phosphate capsules and initiate appropriate treatment if allergic-like reactions occur or are suspected. ·Neuropsychiatric events: Patients with influenza, including those receiving oseltamivir phosphate capsules, particularly pediatric patients, may be at an increased risk of confusion or abnormal behaviour early in their illness. Monitor for signs of abnormal behaviour.
